These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

A participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous ...

Artificial intelligence (AI) can help doctors detect fetal heart defects, improving newborns' chances of survival, a new ...

Portable Ultrasound Market growth is driven by growing demand for non-invasive diagnostic tools and increasing access to healthcare in remote areas.Pune, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Portable ...

Consumer Genomics Market growth is driven by rapid advancements in genetic testing technologies, declining sequencing costs, and increasing consumer awarenessPune, Jan. 31, 2025 (GLOBE NEWSWIRE) -- ...

Renalys Pharma completes patient enrollment in registrational phase III trial of sparsentan for IgA nephropathy in Japan: Tokyo, Japan Friday, January 31, 2025, 18:00 Hrs [IST] Re ...

FDA approved Ryoncil ® as the first and only therapy for pediatric patients 2 months and older, including adolescents and teenagers, with steroid-refractory acute graft versus host disease (SR-aGvHD), ...

The fuel and LPG prices will increase from tomorrow. Consumers will see a two-cent increase in all fuel prices. Motor Spirit ...